Plexxikon - 2001 - 2005 Press Releases

04/06/05	Plexxikon Signs Broad Kinase Screening Collaboration with Invitrogen
12/09/04	Plexxikon and Phenomix to Develop Drug Candidate for Inflammation
10/28/04	Plexxikon and Wyeth Collaborate to Develop Novel Treatments for Diabetes and Metabolic Disorders
05/26/04	Plexxikon Appoints Dr. C. Ronald Kahn of Joslin Diabetes Center to Scientific Advisory Board; Raises $15 Million and Adds New Investors Yamanouchi Ventures and NIF Ventures
11/20/03	Plexxikon and Phenomix Announce Drug Discovery Collaboration for Oncology and Inflammation Target
11/13/03	Plexxikon Highlights Research Findings Key to Drug Discovery for Phosphodiesterase Targets
11/11/03	Plexxikon Achieves Milestone Payment for Lead Compound Selected by Genentech In Drug Discovery Collaboration
05/20/03	Plexxikon and Genentech Announce Drug Discovery Collaboration for Cancer Target
01/15/03	Plexxikon's Scaffold-Based Drug DiscoveryT Platform To Integrate Synthematix' ARTHURT Technology
06/10/02	Plexxikon Chooses Sun Microsystems and Sun Grid Technology to Power Innovative Drug Discovery Platform
04/16/02	Plexxikon Raises $27 Million
04/09/02	Plexxikon Appoints John Kuriyan to Scientific Advisory Board
12/04/01	Plexxikon Signs Agreement with Scynexis to Accelerate Chemistry Efforts
10/31/01	Plexxikon Announces Key Additions to Executive Management Team

2008 | 2007 | 2006

Back to Top

| | | | |

| | | | | | |